CSNK2B and colorectal carcinoma: Meanwhile, considering that there is a discrepancy of CSNK2B gene expression between different datasets, it is necessary to collect clinical and pathological data to further verify the effectiveness of the above findings and explore whether CSNK2B expression is associated with clinicopathological parameters and prognosis of CRC patients in future studies.